Symptoms and Structure of Inhalant Use Disorders
Symptoms and Structure of Inhalant Use Disorders
批准号:
7940804
负责人:
Brian E Perron
金额:
$7.65万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-30 至 2012-08-31
关键词:
AccidentsAddressAdolescentAdultAffectAgeAlcohol or Other Drugs useAlcoholsAreaCessation of lifeCharacteristicsClinicalCommunitiesCriminal JusticeDSM-IVDSM-VDataData SourcesDependenceDevelopmentDiagnosisDiagnosticDiseaseEnsureEpidemiologic StudiesEpidemiologyEvidence based treatmentExhibitsFactor AnalysisFundingGenderGoalsIndividualInhalant dose formKnowledgeLeadLightLiteratureMarijuana SmokingMeasuresMedicalMental HealthMental disordersMentally Ill PersonsMinority GroupsNational Institute of Drug AbuseOrphanOutcomePharmaceutical PreparationsPopulationPrevalencePrincipal InvestigatorPublic HealthReportingResearchResearch PersonnelSamplingScreening procedureSeveritiesSigns and SymptomsStructureSubstance Withdrawal SyndromeSubstance abuse problemSubstance of AbuseSurveysSymptomsSystemTestingValidity and ReliabilityWithdrawalWithdrawal SymptomYouthagedbasecostdrug of abuseimprovedinhalation drug abusemeetingsprogramspsychosocialpublic health relevanceresponsesoundsuccesstheoriestool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by principal investigator): Inhalants are a serious public health concern. They are among the most common and pernicious forms of substance use and the least studied of the major drugs. Inhalant use is associated with harmful outcomes that rival or exceed those characteristic of other drugs of abuse. They disproportionately affect vulnerable subpopulations including the poor, select minority groups, the mentally ill, and persons involved with the juvenile and criminal justice systems. Inhalants can lead to "sudden sniffing death" and serious accidents. Very little research on inhalant use disorders exists, which is also reflected in minimal description of inhalant use disorders in the DSM-IV. Recent findings have raised questions about the reliability and validity of DSM-IV inhalant use disorders, indicating that further research is needed regarding the dimensionality of problematic inhalant use and key signs and symptoms of inhalant use disorders, including tolerance and withdrawal. This information is necessary to inform the development of clinically useful diagnostic and assessment tools, understand the full range of treatment needs of inhalant users, and to develop evidence-based treatments. The importance is elevated in light of the absence of evidenced-based treatments for inhalant use disorders. The proposed research will help address these gaps in knowledge using data from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). NESARC is a nationally representative survey of U.S. residents 18 and older and is among the largest (N= 43,093) and most recently completed psychiatric epidemiological studies. This data source contains DSM-IV concordant data on inhalant-related signs/symptoms and disorders, in addition to Axis I and Axis II psychiatric disorders, for one of the largest community based samples of inhalant users. This study will examine the prevalence, associations, and significance of inhalant symptoms; test the latent structure of DSM-IV inhalant use disorders; and examine diagnostic orphans and alternate symptom configurations of inhalant use disorders.
PUBLIC HEALTH RELEVANCE: This study examines the signs and symptoms associated with using inhalants. The purpose of this study is to better understand the course of inhalant use disorders, with a long-term goal of improving assessment and treatment.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/j.mehy.2009.10.020
发表时间:
2010-05
期刊:
MEDICAL HYPOTHESES
影响因子:
4.7
作者:
[Brower, Kirk J., Perron, Brian E.]
通讯作者:
Perron, Brian E.
Symptoms and Structure of Inhalant Use Disorders
-
批准号:7772029
-
项目类别:
-
资助金额:$7.73万
-
财政年份:2009
-
负责人:Brian E Perron
-
依托单位:
A Population-based Study of Emergency Room Care and Drug Use
-
批准号:7779247
-
项目类别:
-
资助金额:$3.86万
-
财政年份:2009
-
负责人:Brian E Perron
-
依托单位:
Psychiatric Comorbidities and Outpatient Substance Abuse Treatment Retention
-
批准号:7221006
-
项目类别:
-
资助金额:$2.99万
-
财政年份:2006
-
负责人:Brian E Perron
-
依托单位:
海外基金